US Stocks
/
Alumis Inc. Share Price
Alumis Inc. Share Price

Alumis Inc. Share Price

NASDAQ: ALMS | Small Cap
$7.17
+$0.19 (2.72%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Alumis Inc. Stock Performance

Open
$7.02
Prev. Close
$6.98
Circuit Range
N/A
Day Range
$6.91 - $7.29
Year Range
$4.29 - $31.30
Volume
96,475
Average Traded
$7.11

Alumis Inc. Share Price Today

As of 11 October 2026, Alumis Inc.'s share price is $7.17. The stock opened at $7.02, compared to its previous close of $6.98. During today's trading session, Alumis Inc.'s share price traded between $6.91 and $7.29, with an average price of $7.10. Over the past 52 weeks, the stock has recorded a high of $31.30 and a low of $4.29. In terms of performance, Alumis Inc.'s share price has declined by 70.92% over the last six months and is up 51.59% on a year-on-year basis.

Alumis Inc. Share Price Chart

$6.91$7.29
L
Show Current Price
H

Alumis Inc. Stock Fundamentals & Key Indicators

Market Cap
$609.66M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-3.39
Revenue (TTM)
$24.05B
Return On Equity (TTM)
-97.08%
Profit Margin
-1011.77%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-28.66%

Alumis Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$2.07$1.93$1.74$1.66
Net Profit-$110.54-$93.13-$93.05-$142.22
Net Profit Margin-5340.10%-4825.39%-5347.70%-8567.47%
Income ChangeN/A15.75%0.09%-52.84%

Alumis Inc. Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$0.00$24.05
Net Profit-$294.23-$243.33
Net Profit MarginN/A-1011.77%
Income ChangeN/A17.30%

About Alumis Inc.

Alumis Inc is a clinical-stage biopharmaceutical company with an initial focus on developing its two Tyrosine Kinase 2 ("TYK2") inhibitors: envudeucitinib ("envu"), an allosteric TYK2 inhibitor for the treatment of PsO and SLE; and A-005, a central nervous system ("CNS") penetrant allosteric TYK2 inhibitor, to offer the therapeutic benefit of TYK2 inhibition within the CNS for a broad range of neuroinflammatory and neurodegenerative diseases.

Alumis Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$7.36
$7.16
-3.31%
Sep 2026
$9.92
$7.41
-68.08%
Aug 2026
$27.25
$23.20
-17.78%
Jul 2026
$27.65
$28.21
+0.36%
Jun 2026
$20.94
$28.11
+30.17%
May 2026
$25.06
$21.59
-12.43%
Apr 2026
$23.14
$24.66
+11.94%
Mar 2026
$29.00
$22.03
-25.70%
Feb 2026
$24.48
$29.65
+20.97%
Jan 2026
$9.49
$24.51
+151.38%
Dec 2025
$7.67
$9.75
+27.04%
Nov 2025
$4.70
$7.67
+62.26%

ALMS Share Price FAQs

What is Alumis Inc. share price today?

chevron-up
Alumis Inc. share price today is $7.17 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Alumis Inc. stock?

chevron-up
The 52 week high of Alumis Inc. stock is $31.30, while the 52 week low is $4.29 as of 10 Oct '26.

What is ALMS's market capitalisation today?

chevron-up
ALMS market capitalisation is $609.66M as of October 11, 2026, at 5:12 am IST.

What is ALMS's net income for the last quarter?

chevron-up
ALMS's net income for the last quarter is -142.22B USD.

What is the 5 year returns of ALMS?

chevron-up
The 5 year returns of ALMS is -44.42% as on 10 Oct '26.

What is the high & low stock price of ALMS today?

chevron-up
ALMS stock price hit a high of $7.29 and low of $6.91 as of 10 Oct '26.

Can I buy ALMS shares in India?

chevron-up
Yes. You can buy ALMS in India by opening an international trading account.